Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|September 1, 1999
Supplements and Featured Publications
- New Treatments for Rheumatoid Arthritis: A Managed Care Perspective
- Volume 5
- Issue 14 Suppl
Bibliography
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Treatment Options for Rheumatoid Arthritisabout 27 years ago
The Burden of Rheumatoid Arthritisabout 27 years ago
Managed Care Issues and Rheumatoid Arthritis Treatmentabout 27 years ago
Faculty Question-and-Answer Sessionabout 27 years ago
Roundtable I: Practice Patterns for Treating Rheumatoid Arthritisabout 27 years ago
Roundtable II: Cost Concerns for Rheumatoid Arthritis Treatmentabout 27 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
2
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
3
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
4
The Next Frontier in Hepatitis B Functional and Virologic Cure
5